rs1040318543
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000098.3(CPT2):c.1858T>C(p.Trp620Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPT2 | NM_000098.3 | c.1858T>C | p.Trp620Arg | missense_variant | Exon 5 of 5 | ENST00000371486.4 | NP_000089.1 | |
CPT2 | NM_001330589.2 | c.1789T>C | p.Trp597Arg | missense_variant | Exon 5 of 5 | NP_001317518.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251494Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135922
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727248
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74384
ClinVar
Submissions by phenotype
Carnitine palmitoyltransferase II deficiency Uncertain:2
- -
This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 620 of the CPT2 protein (p.Trp620Arg). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CPT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 460430). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CPT2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Carnitine palmitoyl transferase II deficiency, neonatal form Uncertain:1
- -
Carnitine palmitoyl transferase II deficiency, myopathic form Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.1858T>C (p.W620R) alteration is located in exon 5 (coding exon 5) of the CPT2 gene. This alteration results from a T to C substitution at nucleotide position 1858, causing the tryptophan (W) at amino acid position 620 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Encephalopathy, acute, infection-induced, susceptibility to, 4 Uncertain:1
- -
not provided Uncertain:1
- -
Carnitine palmitoyl transferase II deficiency, severe infantile form Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at